HOXD12 and oligodendroglioma: Unfortunately, immunohistochemistry for HOXD12 was not a sufficiently sensitive surrogate marker to detect a difference between HOXD12 gene body methylation levels in a small set of oligodendrogliomas (N = 10) (Supplemental Fig. 13).